featured
Novel Dosing Strategy for Ruxolitinib in the Treatment of Patients With Myelofibrosis and Anemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of a Novel Dosing Strategy for Ruxolitinib in the Treatment of Patients With Myelofibrosis and Anemia: The REALISE Phase 2 Study
Leukemia 2021 May 20;[EPub Ahead of Print], F Cervantes, DM Ross, A Radinoff, F Palandri, A Myasnikov, AM Vannucchi, P Zachee, H Gisslinger, N Komatsu, L Foltz, F Mannelli, F Passamonti, G Gilotti, I Sadek, R Tiwari, E Zor, HK Al-AliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.